✦ LIBER ✦

Single Agent Weekly Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Feasibility Study

✍ Scribed by S. Gupta; R. Bharath; T. Shet; S.B. Desai; V.M. Patil; A. Bakshi; V. Parmar; R.A. Badwe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and high-dose epirubicin as ne

✍ E. Espinosa; S. Morales; P. Borrega; A. Casas; C. Madroñal; I. Machengs; J. A. I 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

Sequential doxorubicine (DOX) and doceta

✍ W. Wynendaele; R. Paridaens; M.R. Christiaens; W. Van den Bogaert; A.T. van Oost 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Phase II Study of Neoadjuvant Weekly nab

✍ Denise A. Yardley; Eric Raefsky; Raul Castillo; Anup Lahiry; Richard LoCicero; D 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 370 KB

A phase II study of epirubicin, cisplati

✍ Kenneth Villman; John F. Öhd; Elisabet Lidbrink; Lena Malmberg; Birgitta Lindh; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Paclitaxel and Carboplatin as Neoadjuvan

✍ Helen Gogas; Dimitrios Pectasides; Ioannis Kostopoulos; Evangelos Lianos; Dimost 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 847 KB

Plasma and Tissue Pharmacokinetics of Ep

✍ Hunz, M; Jetter, A; Warm, M; Pantke, E; Tuscher, M; Hempel, G; Jaehde, U; Untch, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 229 KB